Representative before the EPO

Technology company logo thumb
no operation time available
3 offices
Technology Company

We have observed 17 EP applications Rachel Mary Thornley has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after November 19, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12702153

RSV IMMUNIZATION REGIMEN

IPC classification:
A61P 31/14, A61K 39/155
Applicant:
GlaxoSmithKline Biologicals SA
Applicant:
Novartis AG
Agent:
Multiple attorneys, GlaxoSmithKline
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP12722057

PRE-FUSION RSV F ANTIGENS

IPC classification:
C07K 14/135
Applicant:
GlaxoSmithKline Biologicals SA
Applicant:
Novartis AG
Agent:
Multiple attorneys, GlaxoSmithKline
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP13734111

NOVEL PRIME-BOOSTING REGIMENS INVOLVING IMMUNOGENIC POLYPEPTIDES ENCODED BY POLYNUCLEOTIDES

IPC classification:
A61K 39/155, C12N 15/863, C12N 15/861, C07K 16/44
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Rachel Mary Thornley, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS
EP13752923

METHOD FOR ELICITING IN INFANTS AN IMMUNE RESPONSE AGAINST RSV

IPC classification:
A61K 39/155
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Rachel Mary Thornley, GlaxoSmithKline
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13774498

METHOD FOR ELICITING IN INFANTS AN IMMUNE RESPONSE AGAINST RSV AND B. PERTUSSIS

IPC classification:
A61K 39/155, A61K 39/10, A61K 39/02
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Rachel Mary Thornley, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS
EP13774463

NON-CROSS-LINKED ACELLULAR PERTUSSIS ANTIGENS FOR USE IN COMBINATION VACCINES

IPC classification:
A61K 39/29, A61K 39/102, A61K 39/00
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Rachel Mary Thornley, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS
EP13783578

STAPHYLOCOCCUS AUREUS SDRE CNAB DOMAIN AND ITS USE FOR VACCINATION

IPC classification:
A61K 39/085, C12N 15/00, C07K 14/315
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Rachel Mary Thornley, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS
EP13792915

RSV F PREFUSION TRIMERS

IPC classification:
A61K 39/12, C07K 14/005
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Rachel Mary Thornley, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS
EP14750176

COMBINATION IMMUNOGENIC COMPOSITIONS

IPC classification:
A61K 39/10, A61K 39/00, A61K 39/155, A61K 39/02
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Multiple attorneys, GlaxoSmithKline
Status:
GRANT OF PATENT INTENDED
EP14766824

A CHEMICALLY DEFINED MEDIUM FOR THE INDUSTRIAL SCALE CULTURE OF A SPECIES OF BORDETELLA

IPC classification:
C12N 1/20
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Rachel Mary Thornley, GlaxoSmithKline
Status:
The patent has been granted
EP14819085

PROCESS FOR IDENTIFYING CULTURE CONDITIONS FOR A CELL OR ORGANISM

IPC classification:
C12N 1/20, G06F 19/12
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Rachel Mary Thornley, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP16180926

RECOMBINANT RSV ANTIGENS

IPC classification:
A61K 39/12, C07K 14/005, C12N 15/62, C12N 15/45, C07K 14/135, A61P 37/04, A61P 31/14, A61K 9/127, A61K 9/107, A61K 39/295, A61K 39/155, A61K 39/00, C07K 19/00
Agent:
Rachel Mary Thornley, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP15713531

NOVEL METHODS FOR INDUCING AN IMMUNE RESPONSE

IPC classification:
A61K 39/04
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Rachel Mary Thornley, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP16188862

IMMUNOGENIC COMPOSITIONS AND METHODS FOR TREATING NEUROLOGIC DISORDERS

IPC classification:
A61K 31/7056, A61K 31/7008, A61K 31/00, A61K 39/39, A61P 25/28, A61K 39/00, A61K 39/395
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Rachel Mary Thornley, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP15733370

IMMUNOGENIC COMBINATIONS

IPC classification:
C07K 14/135, A61K 39/235
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Rachel Mary Thornley, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP15813347

VACCINATION

IPC classification:
A61K 39/12, A61K 39/25
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Multiple attorneys, GlaxoSmithKline
Status:
Request for examination was made
EP16730773

ADENOVIRUS POLYNUCLEOTIDES AND POLYPEPTIDES

IPC classification:
A61K 39/00, A61K 39/12, C12N 15/861, C07K 14/075, A61K 39/235
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Rachel Mary Thornley, GlaxoSmithKline
Status:
Request for examination was made

Please Sign in to use this feature